| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mesoblast Limited (MEOBF) has 1 insider with recent SEC Form 4 filings, including 30 buys and 0 sells. MEOBF is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.32M | $12.90M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2026 | George Gregory | Director, 10% Owner | Buy | 7,910,962 | $1.44 | $11,396,976.86 | +4.2% | |
| Apr 10, 2026 | George Gregory | Director, 10% Owner | Buy | 8,305,962 | $3.15 | $26,135,093.26 | +4.4% |